Takeda Pharmaceuticals to lay off 247 employees in Massachusetts

Largest biopharma employer in the state cites high costs and business environment as reasons for cuts

Apr. 2, 2026 at 8:22pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of pharmaceutical pill bottles and vials arranged elegantly on a clean, white background, conceptually representing the corporate challenges facing the industry in Massachusetts.As Massachusetts' largest biopharma employer cuts jobs, the state's business climate faces growing scrutiny.Cambridge Today

Takeda Pharmaceuticals, the largest biopharma employer in Massachusetts, is laying off 247 employees at its Cambridge location in July as the company implements a restructuring plan to cut costs. The layoffs are part of a broader effort that will also see an additional 387 job cuts in other states, with the company citing high taxes, climate mandates, and an unfriendly business environment in Massachusetts as driving factors.

Why it matters

The Takeda layoffs are the latest in a string of major companies either leaving Massachusetts or cutting jobs in the state, raising concerns about the state's ability to retain businesses and talent amid rising costs and an increasingly challenging regulatory environment.

The details

Takeda Pharmaceuticals filed an official notice with the state on March 25 stating that the layoffs, all of which will affect employees at the company's 500 Kendall Street location in Cambridge, will begin in July. The company says the job cuts are part of a new restructuring plan approved by its board of directors that is aimed at cutting $1.3 billion in costs. Takeda says affected employees will receive a 60-day termination notice and be offered severance packages, outplacement assistance, and opportunities for internal redeployment.

  • Takeda filed the layoff notice on March 25, 2026.
  • The 247 layoffs in Massachusetts will begin in July 2026.
  • An additional 387 layoffs at Takeda locations in other states are also planned.

The players

Takeda Pharmaceuticals USA, Inc.

The largest biopharma employer in Massachusetts, headquartered in Cambridge.

Massachusetts Fiscal Alliance

A conservative advocacy group that criticized the state's business environment in response to the Takeda layoffs.

Massachusetts state government

The state government has acknowledged high housing costs as a driver of outmigration, while also citing population growth from international immigration as offsetting this trend.

Got photos? Submit your photos here. ›

What they’re saying

“High taxes…Climate NetZero mandate…This Governor… You get: Takeda to cut 247 Mass. jobs, at Massachusetts' largest life sciences employer…”

— Massachusetts Fiscal Alliance

“People move away from MA for many reasons, but housing cost is at the top of the list for many. High costs make it difficult or expensive for companies to locate and expand in MA. Outmigration to other states varies over the years but has long been offset through population growth from international immigration.”

— Massachusetts state government

What’s next

Takeda says it will continue to monitor the situation and provide additional updates if further impacts are identified. The state government has acknowledged the challenges facing Massachusetts in retaining businesses and talent, but has pointed to international immigration as a mitigating factor.

The takeaway

The Takeda layoffs underscore the growing exodus of major companies from Massachusetts, driven by a combination of high costs, an unfriendly business climate, and an inability to retain talent. This trend raises serious questions about the long-term economic health of the state and the effectiveness of its policies in supporting the growth of key industries like life sciences.